secwatch.observer — SEC 8-K summary
======================================

Issuer:     ACTUATE THERAPEUTICS, INC. (ACTU)
CIK:        0001652935
Form:       8-K
Filed at:   2025-11-28T23:59:59+00:00
Accession:  0001683168-25-008732
Event type: other_material
Sentiment:  neutral
Materiality: 0.55
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Actuate Therapeutics enters $100M ATM equity offering agreement with B. Riley and Craig-Hallum
--------------------------------------------------------------------------------

- Agreement allows sale of up to $100M of common stock through agents B. Riley Securities and Craig-Hallum Capital Group.
- Sales will be made under existing S-3 shelf registration; agents receive 3.0% commission on gross proceeds.
- Offers may be executed as at-the-market, privately negotiated, or block transactions at company's discretion.
- Company provides customary indemnification to the sales agents.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1652935/000168316825008732/0001683168-25-008732-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1652935/000168316825008732/actuate_8k.htm
  HTML page:      https://secwatch.observer/filing/0001683168-25-008732

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer